6565 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1978)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of breast density on the presenting features of malignancy
    Journal Article

    Arora, N.; King, T. A.; Jacks, L. M.; Stempel, M. M.; Patil, S.; Morris, E.; Morrow, M.
    Annals of Surgical Oncology (2010)

    Fulltext@MSK | Save
  • Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer
    Journal Article

    Akin, O.; Riedl, C. C.; Ishill, N. M.; Moskowitz, C. S.; Zhang, J.; Hricak, H.
    European Radiology (2010)

    Fulltext@MSK | Save
  • A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care
    Journal Article

    Abu-Rustum, N. R.; Zhou, Q.; Gomez, J. D.; Alektiar, K. M.; Hensley, M. L.; Soslow, R. A.; Levine, D. A.; Chi, D. S.; Barakat, R. R.; Iasonos, A.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: A randomized trial
    Journal Article

    Abou-Alfa, G. K.; Johnson, P.; Knox, J. J.; Capanu, M.; Davidenko, I.; Lacava, J.; Leung, T.; Gansukh, B.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2010)

    Fulltext@MSK | Save
  • A "no-wash" albumin-dextran dilution strategy for cord blood (CB) thaw is associated with a high rate of engraftment and a low incidence of serious infusion reactions
    Meeting Abstract

    Rice, R. D.; Abboud, M.; Hawke, R. M.; Schaible, A. M.; Heller, G.; Scaradavou, A.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up
    Meeting Abstract

    Rudloff, U.; Brogi, E.; McCormick, B.; Brockway, J. P.; Goldberg, J. I.; Wynveen, C. A.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The clinical impact and outcomes of immunohistochemistry-only metastases in breast cancer
    Meeting Abstract

    Pugliese, M. S.; Stempel, M. M.; Patil, S. M.; Hsu, M.; Cody, H. S. 3rd; Morrow, M.; Gemignani, M. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Meeting Abstract

    Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save